Israel · Legal status and models

Open legal reference book and annotated papers on a quiet desk in a legal research room; editorial illustration only.
Editorial illustration only; it does not depict a real authority, clinic, approval or legal document.

Surrogacy in Israel: what the law permits, restricts and leaves to review

The short answer

Israel permits domestic gestational surrogacy, but only within a statutory approval system. The central instrument is the Embryo Carrying Agreements (Agreement Approval and Status of the Newborn) Law, 5756-1996. The framework is neither a blanket prohibition nor an unrestricted commercial market: the intended parents and surrogate must meet eligibility conditions, the written agreement must receive advance approval from the statutory committee, and payments must stay within the terms it approves. An agreement signed privately is not a substitute for approval.

The current Ministry of Health guidance lists couples and individual intended mothers or fathers as possible applicants, subject to the other legal requirements. This broader access follows the Supreme Court’s 2021 remedy concerning exclusions of single men and same-sex couples, which the Ministry’s implementation circular says took effect on 11 January 2022. That change did not remove the residence, genetic-link, health, age, child-welfare or approval requirements.

Which rules control, and how strong is the evidence?

The primary framework is the 1996 statute as amended and interpreted, read together with relevant legislation on egg donation and patient rights, binding Supreme Court decisions, and valid Ministry of Health implementation instructions. The Ministry’s English service page is useful official administrative guidance, but it expressly says that the law prevails if the page and legislation conflict. A committee checklist or clinic practice is not itself a statute; it may explain how an application is processed but cannot lawfully displace the governing law.

The Ministry says the law prevails over its page summary. The current consolidated Hebrew text, the circular and any extension of the temporary 2025 order still require confirmation by Israeli counsel or the competent authority.

What kind of surrogacy model is this?

The statutory model is gestational surrogacy under an approved agreement: the Ministry describes an arrangement in which a fertilized ovum is implanted in a carrying mother, who carries the pregnancy for the designated parents. At least one intended parent must have a genetic connection to the child through a gamete used for IVF. This should not be described as a general permission for every form of surrogacy, every genetic arrangement or every cross-border programme.

Israel’s model is compensated, but tightly regulated. The law allows the approval committee to authorize specified payments, including actual expenses and reasonable compensation for time, suffering or loss of income. That does not make any amount or private payment lawful. The committee must approve the payment terms, and the parties must follow the approved agreement and its conditions. The most accurate short description is therefore “regulated, committee-approved compensated surrogacy”, rather than either “altruistic only” or “unrestricted commercial surrogacy”.

Who may be an intended parent?

The Ministry’s current guidance says an application may be made by a couple or by an individual intended mother or intended father. The intended parent must be at least 18; the guidance normally requires at least one intended parent to be no older than 54, although the committee may approve an agreement in a special case even where the maximum-age condition is not met. A couple must not already have more than two children together; an individual must not have more than two genetic children under the Ministry’s stated test.

The intended parents must be Israeli residents. Residence should not be casually equated with citizenship, a short stay or the possession of a particular passport: the applicable legal and administrative definition must be checked for the facts. At least one gamete used for IVF must come from an intended parent. Under the Ministry’s stated eligibility condition, an intended parent is disqualified if convicted in Israel or abroad of an offence whose nature, seriousness or circumstances create a real concern of significant harm to the future child’s welfare. If proceedings concerning such an offence are pending, the committee may defer its decision until they end; the Ministry defines proceedings as beginning when an investigation is opened under law. The Ministry says ova from an intended mother or donor may be used only if retrieved before age 43; a single intended mother must use her own ovum. A temporary order provided a one-year bereavement exception beginning on 11 March 2025, temporarily raising the relevant child-number cap to three for specified intended parents whose child had died. The available text indicates that the period ended in March 2026; no extension was found in the sources, and the Ministry’s current page still states the ordinary two-child limit. Confirm the current position with the National Supervisor before relying on any exception. Medical, psychological and other documents vary by applicant profile. For two intended fathers (or two intended parents with male gametes), the sperm used for fertilization must come from one of the intended parents; sperm from both cannot be mixed in a single fertilization, and embryos from two intended fathers cannot be transferred to the surrogate in the same treatment cycle. If separate fertilization cycles use ova fertilized by different sperm, the surrogate’s prior consent must be included in the agreement. Confirm the current checklist for the specific case.

Who may act as a surrogate?

The Ministry’s published criteria require the surrogate (the law’s “carrying mother”) to be an Israeli resident aged at least 22 but under 39 when the agreement is approved. She must previously have been pregnant and given birth other than as a surrogate; her children must not have been removed from her custody under any law. She must not be related to either intended parent and must meet the committee’s medical and other suitability requirements.

The current Ministry checklist sets specific limits: no more than four previous childbirths; by the time the complete application is submitted, at least 12 months must have elapsed after a vaginal birth or 18 months after a caesarean (medical checks and document collection may begin no earlier than 11 or 15 months, respectively). The surrogate must not have acted as a surrogate more than twice or given birth as a surrogate more than once. The committee will not approve an agreement if both previous surrogacy processes ended in births; if one ended in birth and the other reached six embryo transfers; or if both processes were completed and each involved six transfers. Previous births must have been full-term, with normal birth weight for gestational age and no significant medical complications during pregnancy or childbirth. Check the current checklist before matching or incurring costs.

The ordinary rule is that the surrogate is unmarried. A married woman may be considered only if the committee is satisfied that reasonable efforts did not produce an agreement with an unmarried surrogate, and her spouse must be informed of the process and given an opportunity to state a position before the committee. The surrogate is generally required to be of the same religion as the intended mother or father; the Ministry describes a limited power to depart from that rule where all parties are not Jewish, based on an opinion from the committee’s religious member. Health history, informed consent, insurance and psychological assessment are also relevant. Exact medical exclusions and documentary requirements should be taken from the current official checklist, not inferred from this high-level article.

Why prior committee approval matters

The statutory Approval Committee is the gatekeeper for a domestic surrogacy agreement. The Ministry describes a seven-member body including specialists in obstetrics and gynaecology, an internal-medicine physician, a clinical psychologist, a social worker, a public representative who is a jurist, and a religious official connected with the parties’ religion. Its task is not merely to register a contract after the fact: it reviews whether the statutory conditions are met and whether the agreement and surrounding arrangements are acceptable.

The parties sign the approved agreement in the committee’s presence; only then does the Ministry’s described process authorize commencement. Approval may be reconsidered if a material fact or circumstance changes before embryo implantation. An initial or threshold-eligibility review, where available, is not a guarantee that the final agreement will be approved. Applicants should obtain the current forms and submission instructions directly from the Ministry before incurring irreversible costs.

The agreement must reflect real, informed consent

The agreement must be voluntary and made with an understanding of its meaning and consequences. The Ministry’s summary of the law identifies the absence of a concern for the surrogate’s health and the child’s welfare as approval considerations, and states that the agreement must cap embryo-implantation attempts at no more than six.

The Ministry instructs intended parents and the surrogate to have separate lawyers with relevant Israeli surrogacy experience. The surrogate must have independent advice, and the process includes medical and psychological documentation, insurance information and discussion of the parties’ expectations. The written agreement should be consistent with the terms the committee actually approves. A material change, side letter or changed payment arrangement should be referred to the lawyers and, where required, the committee before it is implemented. Consent and contract formalities do not remove the committee’s statutory oversight.

Compensation: permitted, but not unrestricted

The law does not confine every domestic arrangement to reimbursement of out-of-pocket expenses alone. According to the Ministry’s summary, the committee may approve monthly payments to cover actual costs associated with the agreement, including legal advice and insurance premiums, and compensation for loss of time, suffering, loss of income, temporary loss of earning capacity or other reasonable compensation. The specific terms require approval; the statute is not a licence for the parties to choose any fee they wish.

The Ministry’s summary also states that a party, or a person seeking to become a party, may not give or receive money or money’s worth for carrying out the agreement except for payments approved by the committee. Do not pay a “deposit”, bonus, agency charge passed to the surrogate, expense supplement or other benefit on the assumption that it is automatically lawful. The legal character of a payment depends on its purpose, amount, documentation and the approval terms. The committee’s current rules and the proposed agreement should be checked before funds move. The Ministry’s guidance says a trustee may be selected during preparation, but the consideration money should not yet be deposited at that stage.

What is prohibited, and which exceptions are narrow?

The clearest statutory prohibition in the Ministry’s summary is entering into a surrogacy agreement that the committee has not approved, or carrying out an unapproved agreement or one that departs from the approved agreement or approval conditions. Giving or accepting compensation outside the committee-approved terms is also prohibited under the Ministry’s summary. A clinic’s willingness to perform a procedure, a broker’s promise or a private contract cannot replace the statutory approval.

Exceptions are specific, not a general discretion to ignore the system. The committee may in a special case approve an agreement despite the ordinary maximum-age condition. A married surrogate may be considered only under the conditions described above. The committee may allow part of a pregnancy to take place outside Israel for reasons it accepts and subject to its conditions. A limited religious exception is described where all parties are not Jewish. Each exception depends on the legal wording and a competent decision; none should be treated as automatic or assumed from a clinic’s usual practice.

Where must the domestic programme take place?

The Ministry’s summary of the 1996 law states that the IVF procedure for implantation, implantation of the fertilized ovum in the surrogate, the pregnancy for the intended parents and the birth are to take place in Israel. It also says the approval committee may permit part of the pregnancy to take place outside Israel where there are justifying reasons and on conditions set by the committee. This is a narrow, case-specific permission, not a blanket authorization to move a domestic programme abroad.

The Ministry’s current page separately lists an extension of approval to import fertilized eggs from abroad for surrogacy in Israel through August 2027. This is not blanket permission to carry out IVF, implantation, pregnancy or birth abroad; confirm whether the extension applies and what approval it requires.

Do not confuse this territorial rule with the separate question whether an Israeli resident may enter into a programme abroad, or whether another country will recognize the resulting parentage. Those questions engage different laws and authorities. If a medical procedure, embryo, surrogate or birth is planned outside Israel, obtain written advice on whether the domestic agreement can accommodate it and whether committee approval is required before any step is taken. Do not rely on a general website, clinic advertisement or an informal assurance that the arrangement is “internationally accepted”.

Birth, parentage, nationality and overseas arrangements are separate questions

The law’s title expressly addresses the status of the newborn, but committee approval of the agreement should not be treated as a universal answer to every post-birth issue. The applicable process for legal parentage, registry records, birth documentation and any court or administrative order must be confirmed under the current Israeli rules for the specific case.

Nationality, a passport and permission to leave Israel are also distinct from the approval of the surrogacy agreement and from parentage recognition in another country. A genetic link can be relevant to eligibility without, by itself, resolving every nationality or immigration question. For a programme involving foreign intended parents, a surrogate or a birth abroad, analyse the law of the place of the procedure and birth, the intended parents’ nationality and residence, and the destination country’s parentage rules separately. The domestic route’s Israeli-residence condition means non-residents should not assume they can qualify for approval in Israel. Overseas surrogacy may be possible under another jurisdiction’s rules, but that does not establish recognition, travel clearance or compliance with Israeli law.

At-a-glance legal matrix

The matrix below separates the main legal questions. It is a screening aid, not a substitute for checking the current statute, official guidance and the facts of a proposed arrangement.

IssueCurrent position described by the MinistryBoundary / caution
Legal basisThe 1996 statute, interpreted and implemented through applicable decisions and official instructions.The consolidated Hebrew text and amendments still require verification.
Who may applyA couple or an individual intended mother/father, subject to Israeli residence and other eligibility rules.The Ministry currently states a two-child limit; a one-year bereavement exception began on 11 March 2025 and appears to have ended in March 2026. No extension was found; confirm directly before relying on it.
Payment modelCompensation and expenses may be approved by the committee.No unrestricted fee or side payment outside approved terms.
AgreementPrior committee approval is required; the approved agreement controls performance.A private signature, clinic acceptance or agency promise is not enough.
PlaceDomestic procedures and birth are generally in Israel.Part of the pregnancy abroad requires a committee decision and conditions. The Ministry page separately lists an import-approval extension for fertilized eggs from abroad through August 2027; confirm the full current official terms.
After birthParentage, documents, nationality and travel require separate checks.Agreement approval alone does not answer every post-birth or foreign-law question.

Safe next steps and limits of this guide

Before paying an agency, selecting a clinic or signing a document, ask an Israeli lawyer experienced in surrogacy to confirm (1) the current consolidated Hebrew statute and amendments; (2) the intended parents’ residence, age, child-number, genetic and medical eligibility; (3) the surrogate’s residence, age, marital, religious, medical and consent requirements; (4) the committee’s current application checklist and timing; (5) every proposed payment and trust-account step; and (6) the approved territorial plan. Keep written confirmation of the legal basis for any exception. Do not start IVF or transfer embryos until the required approval is in place.

If the facts involve treatment or birth outside Israel, obtain separate advice on parentage, nationality, registry documents, travel and recognition in each relevant country. This guide does not verify every current committee instruction or post-birth rule; an Israeli lawyer should confirm the current consolidated Hebrew statute and any extension of the 2025 temporary order.

Sources and verification limits

Source-status note: the Ministry page was directly accessed, but blocked official downloads are not treated as verification of the complete official texts. The secondary statutory transcription is not an official publication.

Guides for Israel

Last updated:

Author: Khachatrian Razmik, LL.M.

International surrogacy and parentage legal services — LEX SURROGACY by Lex Agency · Author profile · Editorial standards